[company_age]7.0[/company_age][employees]11-50 employees[/employees][funding]Série inconnue[/funding][description]C4Diagnostics is a French biotechnology company founded in 2017 that specializes in developing in vitro diagnostic (IVD) tests for human infectious diseases. The company's approach to better management of human infectious diseases is to develop IVD tests that are faster than reference methods while ensuring comparable or even superior performance. Its portfolio is currently focused on the diagnosis of Covid-19 (C4Covid-19 Human), legionellosis (C4Legio-LFA), urinary tract infections (C4UTI), and the establishment of antibiograms (C4AST). C4Diagnostics also has a Business Unit dedicated to environmental diagnostics, called C4Environment. It offers a service activity for the detection of the SARS-CoV-2 virus and other pathogens (viruses, bacteria, molds, and yeasts) in the environment (wastewater, air, surfaces). C4Diagnostics has contributed to several Covid-19 surveillance and prevention campaigns since the beginning of the pandemic. C4Diagnostics aims to become one of the main players in the field of human infectious disease diagnostics, by quickly providing healthcare professionals with reliable diagnostic information to improve patient care. The diagnostic solutions developed by C4Diagnostics are a lever to fight against antibiotic resistance and stop infectious disease epidemics.[/description][ps]In vitro diagnostic (IVD) tests for human infectious diseases, environmental diagnostics[/ps]